Sanofi
Trispecific and/or trivalent binding proteins
Last updated:
Abstract:
The disclosure provides trispecific and/or trivalent binding proteins comprising four polypeptide chains that form three antigen binding sites that specifically bind one or more target proteins, wherein a first pair of polypeptides forming the binding protein possess dual variable domains having a cross-over orientation and wherein a second pair of polypeptides forming the binding protein possess a single variable domain. The disclosure also provides methods for making trispecific and/or trivalent binding proteins and uses of such binding proteins.
Status:
Grant
Type:
Utility
Filling date:
16 Nov 2020
Issue date:
7 Dec 2021